“…However, constitutive expression of PD-L1 is far less common than IFN induced PD-L1 expression. PD-L1 is expressed in various cancers: gastric cancer (50), melanoma (51), nasopharyngeal carcinoma (52), posttransplant lymphoproliferative disorder (53), non-small cell lung cancer (54), pancreatic cancer (55), lymphomas (56), bladder cancer (57), kidney cancer (58), breast cancer (59), and Hodgkin lymphoma (60) . Other than EBV, multiple human herpes virus infections have also been found to result in increased PD-L1 expression such as herpes simplex virus (61), Varicella zoster virus (62), Cytomegalovirus (63), Human herpesvirus 6 (64), and Kaposi's sarcoma-associated herpesvirus (65).…”